Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I, Wei, Y, Starczynowski, D T, Colla, S, Yang, H, Cabrero-Calvo, M, Bohannan, Z S, Verma, A, Steidl, U, Garcia-Manero, G
Published in Leukemia (01.07.2015)
Published in Leukemia (01.07.2015)
Get full text
Journal Article
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition
Ju, H-Q, Zhan, G, Huang, A, Sun, Y, Wen, S, Yang, J, Lu, W-h, Xu, R-h, Li, J, Li, Y, Garcia-Manero, G, Huang, P, Hu, Y
Published in Leukemia (01.10.2017)
Published in Leukemia (01.10.2017)
Get full text
Journal Article
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
DiNardo, C D, Jabbour, E, Ravandi, F, Takahashi, K, Daver, N, Routbort, M, Patel, K P, Brandt, M, Pierce, S, Kantarjian, H, Garcia-Manero, G
Published in Leukemia (01.04.2016)
Published in Leukemia (01.04.2016)
Get full text
Journal Article
Toll-like receptor alterations in myelodysplastic syndrome
Wei, Y, Dimicoli, S, Bueso-Ramos, C, Chen, R, Yang, H, Neuberg, D, Pierce, S, Jia, Y, Zheng, H, Wang, H, Wang, X, Nguyen, M, Wang, S A, Ebert, B, Bejar, R, Levine, R, Abdel-Wahab, O, Kleppe, M, Ganan-Gomez, I, Kantarjian, H, Garcia-Manero, G
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
Mallo, M, Cervera, J, Schanz, J, Such, E, García-Manero, G, Luño, E, Steidl, C, Espinet, B, Vallespí, T, Germing, U, Blum, S, Ohyashiki, K, Grau, J, Pfeilstöcker, M, Hernández, J M, Noesslinger, T, Giagounidis, A, Aul, C, Calasanz, M J, Martín, M L, Valent, P, Collado, R, Haferlach, C, Fonatsch, C, Lübbert, M, Stauder, R, Hildebrandt, B, Krieger, O, Pedro, C, Arenillas, L, Sanz, M Á, Valencia, A, Florensa, L, Sanz, G F, Haase, D, Solé, F
Published in Leukemia (01.01.2011)
Published in Leukemia (01.01.2011)
Get full text
Journal Article
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
Wei, Y, Chen, R, Dimicoli, S, Bueso-Ramos, C, Neuberg, D, Pierce, S, Wang, H, Yang, H, Jia, Y, Zheng, H, Fang, Z, Nguyen, M, Ganan-Gomez, I, Ebert, B, Levine, R, Kantarjian, H, Garcia-Manero, G
Published in Leukemia (01.11.2013)
Published in Leukemia (01.11.2013)
Get full text
Journal Article
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy
DiNardo, C D, Daver, N, Jain, N, Pemmaraju, N, Bueso-Ramos, C, Yin, C C, Pierce, S, Jabbour, E, Cortes, J E, Kantarjian, H M, Garcia-Manero, G, Verstovsek, S
Published in Leukemia (01.04.2014)
Published in Leukemia (01.04.2014)
Get full text
Journal Article
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
Fabbri, M, Garzon, R, Andreeff, M, Kantarjian, H M, Garcia-Manero, G, Calin, G A
Published in Leukemia (01.06.2008)
Published in Leukemia (01.06.2008)
Get full text
Journal Article
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia
Kuang, S-Q, Tong, W-G, Yang, H, Lin, W, Lee, M K, Fang, Z H, Wei, Y, Jelinek, J, Issa, J-P, Garcia-Manero, G
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article
Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
Ok, C Y, Hasserjian, R P, Fox, P S, Stingo, F, Zuo, Z, Young, K H, Patel, K, Medeiros, L J, Garcia-Manero, G, Wang, S A
Published in Leukemia (01.01.2014)
Published in Leukemia (01.01.2014)
Get full text
Journal Article
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation
Chen, Y, Kantarjian, H, Pierce, S, Faderl, S, O'Brien, S, Qiao, W, Abruzzo, L, de Lima, M, Kebriaei, P, Jabbour, E, Daver, N, Kadia, T, Estrov, Z, Garcia-Manero, G, Cortes, J, Ravandi, F
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND T(6;9)(P22;Q34)
Ong, F., Kadia, T. M., Short, N. J., Yilmaz, M., Alvarado, Y., Pierce, S., Garcia‐Manero, G., DiNardo, C., Borthakur, G., Konopleva, M., Daver, N., Kantarjian, H., Ravandi, F.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS
Senapati, J., Verstovsek, S., Masarova, L., Pemmaraju, N., Montalban Bravo, G., Pierce, S., Zhou, L., Garcia‐Manero, G., Kantarjian, H., Bose, P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT‐NAIVE PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS
Hasegawa, K., Wei, A. H., Garcia‐Manero, G., Daver, N. G., Rajakumaraswamy, N., Iqbal, S., Chan, R. J., Hu, H., Tse, P., Yan, J., Zoratti, M. J., Xie, F., Sallman, D. A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P496: CLINICAL CHARACTERISTICS OF SECONDARY MYELOID NEOPLASMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Abuasab, T., Mohadam, S. F., Hwang, H., Wang, X., Sasaki, K., Yilmaz, M., Kadia, T., DiNardo, C., Daver, N., Pemmaraju, N., Borthakur, G., Ravandi, F., Garcia‐Manero, G., Takahashi, K.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P778: LONG‐TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) FROM THE MEDALIST TRIAL
Fenaux, P., Santini, V., Komrokji, R. S., Zeidan, A., Garcia‐Manero, G., Buckstein, R., Miteva, D., Keeperman, K., Holot, N., Zhang, J., Nadal, J. A., Rosettani, B., Yucel, A., Platzbecker, U.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P781: CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH LR‐MDS REINITIATING ESAS FOLLOWING PREVIOUS ESA TREATMENT
Garcia‐Manero, G., Matsuno, R. K., McBride, A., Brown, T. D., Idryo, D., Broome, R., Herriman, A., Johnson, T., Wilkinson, K., Walters, S., Schrag, A., Johanson, C., Izano, M., Mukherjee, S.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P762: NONLINIEAR IMPACT OF CLINICAL FEATURES ON THE SURVIVAL OUTCOME OF MYELODYSPLASTIC SYNDROMES PATIENTS
Darbaniyan, F., Montalban Bravo, G., Chien, K. S., Kanagal Shamanna, R., sasaki, K., Yang, H., Soltysiak, K. A., Li, Z., Do, K.‐A., Garcia‐Manero, G.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION
Abuasab, T., Jabbour, E., Short, N., Konopleva, M., Chien, K. S., Fareed Mohamed, S., Daver, N., Kanagal‐shamanna, R., Garcia‐Manero, G., Montalban‐Bravo, G.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article